Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, November 8, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Richard Law Maintained (BEAM) at Hold with Decreased Target to $53 on, Nov 8th, 2022
Richard Law of Credit Suisse, Maintained "Beam Therapeutics Inc." (BEAM) at Hold with Decreased Target from $65 to $53 on, Nov 8th, 2022.
Richard has made no other calls on BEAM in the last 4 months.
There are 3 other peers that have a rating on BEAM. Out of the 3 peers that are also analyzing BEAM, 1 agrees with Richard's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Gena Wang of "Barclays" Maintained at Hold with Increased Target to $60 on, Wednesday, August 10th, 2022
These are the ratings of the 2 analyists that currently disagree with Richard
- Mani Foroohar of "SVB Leerink" Maintained at Buy with Decreased Target to $81 on, Monday, November 7th, 2022
- Rick Bienkowski of "SVB Leerink" Maintained at Buy with Decreased Target to $113 on, Wednesday, August 10th, 2022
